Fig. 2

Pilot genomic screening program. Schematic outlining a pilot genomic screening program to return clinically confirmed pathogenic and likely pathogenic (P/LP) variants in genes related to hereditary breast and ovarian cancer syndrome (HBOC), Lynch syndrome (LS), familial hypercholesterolemia (FH), and hereditary transthyretin amyloidosis (hATTR)